Betafectin

Betafectin

A recombinant beta-glucan immunomodulator which was thought to reduce the risk of staphylococcal wound infection. It made it to phase-III clinical trials to prevent serious postoperative infection in GI surgical patients—e.g., for Crohn’s disease or ulcerative colitis.